JPH0216727B2 - - Google Patents

Info

Publication number
JPH0216727B2
JPH0216727B2 JP57102393A JP10239382A JPH0216727B2 JP H0216727 B2 JPH0216727 B2 JP H0216727B2 JP 57102393 A JP57102393 A JP 57102393A JP 10239382 A JP10239382 A JP 10239382A JP H0216727 B2 JPH0216727 B2 JP H0216727B2
Authority
JP
Japan
Prior art keywords
effect
rheumatoid arthritis
platonin
compound
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57102393A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58219116A (ja
Inventor
Itaru Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP10239382A priority Critical patent/JPS58219116A/ja
Priority to US06/404,843 priority patent/US4464383A/en
Priority to DE19823234711 priority patent/DE3234711A1/de
Priority to CH5540/82A priority patent/CH650673A5/de
Priority to GB08227128A priority patent/GB2116422B/en
Priority to BE0/209198A priority patent/BE894635A/fr
Priority to FR8216813A priority patent/FR2516793B1/fr
Publication of JPS58219116A publication Critical patent/JPS58219116A/ja
Publication of JPH0216727B2 publication Critical patent/JPH0216727B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10239382A 1981-11-24 1982-06-14 慢性関節リウマチ治療剤 Granted JPS58219116A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP10239382A JPS58219116A (ja) 1982-06-14 1982-06-14 慢性関節リウマチ治療剤
US06/404,843 US4464383A (en) 1981-11-24 1982-08-03 Immunomodulator containing trithiazole pentamethine cyanine derivative
DE19823234711 DE3234711A1 (de) 1981-11-24 1982-09-18 Ein trithiazolpentamethincyaninderivat enthaltender immunomodulator
CH5540/82A CH650673A5 (de) 1981-11-24 1982-09-20 Ein trithiazolpentamethincyaninderivat enthaltendes pharmazeutisches mittel.
GB08227128A GB2116422B (en) 1981-11-24 1982-09-23 Immunomodulator containing trithiazole pentamethine cyanine derivative
BE0/209198A BE894635A (fr) 1981-11-24 1982-10-07 Nouveaux medicaments immunomodulateurs contenant un derive de trithiazole-pentamethylidene cyanine
FR8216813A FR2516793B1 (fr) 1981-11-24 1982-10-07 Nouveaux medicaments immunomodulateurs contenant un derive de trithiazolepentamethylidene-cyanine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10239382A JPS58219116A (ja) 1982-06-14 1982-06-14 慢性関節リウマチ治療剤

Publications (2)

Publication Number Publication Date
JPS58219116A JPS58219116A (ja) 1983-12-20
JPH0216727B2 true JPH0216727B2 (OSRAM) 1990-04-18

Family

ID=14326197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10239382A Granted JPS58219116A (ja) 1981-11-24 1982-06-14 慢性関節リウマチ治療剤

Country Status (1)

Country Link
JP (1) JPS58219116A (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4580479B2 (ja) * 1998-12-21 2010-11-10 株式会社林原生物化学研究所 抗ｈｉｖ感染症剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1169660A (en) * 1968-01-31 1969-11-05 Eisai Co Ltd Quarternary Compounds

Also Published As

Publication number Publication date
JPS58219116A (ja) 1983-12-20

Similar Documents

Publication Publication Date Title
US4734276A (en) L-lysine pyruvate and l- histidine pyruvate and their use in therapy of tissue and mucosa damage
EP0001727B1 (fr) Nouveaux dérivés du phényl-4-(trichloro-2',2',2'-éthoxycarboxamido)-2-thiazole utiles comme médicaments, compositions pharmaceutiques les contenant et leur procédé de préparation
US3644626A (en) Novel pyridones in compositions and methods for treating inflammation pain and fever
CA1297033C (en) Use of carboxylic acid amides for treating inflammations
JPH0475205B2 (OSRAM)
JPH0216727B2 (OSRAM)
NL8105635A (nl) Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
US4464383A (en) Immunomodulator containing trithiazole pentamethine cyanine derivative
JPS60158149A (ja) 炎症抑制作用を有する１，４‐ナフトキノン誘導体
EP0194571B1 (de) Heterocyclische Disulfide, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten
HUP0203790A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére
US3852454A (en) Treatment of rheumatoid arthritis
JP2005507869A (ja) 特殊構造を持つ新規抗癌化合物の一群
EP0623623B1 (en) 2-aminoethanesulfonic acid/zinc complex
US3222253A (en) Antimitotic colchicines
US3885045A (en) Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamine
JPS5835186A (ja) ジカルボキシアミノチアゾール誘導体およびそれを含有する免疫調節組成物
Capasso et al. The effects of levamisole and d-penicillamine on some inflammatory models in vivo and on PG production in vitro
CA1270762A (fr) Compositions pharmaceutiques renfermant un derive de l'acide maleopimarique
JPH04210631A (ja) 消化管壁保護剤
JPH0216285B2 (OSRAM)
JPS6245525A (ja) 脂質低下剤
KR920001762B1 (ko) 과요산혈증치료제
JPS6245843B2 (OSRAM)
EP0169785B1 (fr) Utilisation du triacétoxy-1,8,9 anthracène comme ingredient actif dans la préparation d'un médicament anti-tumoral